As a result, PD‐1, PD‐L1, CTLA‐4, TIM‐3, and LAG3 expression significantly increased among high‐risk HCC patients relative to low‐risk counterparts (P < .05). This evidence concerns the gene HAVCR2 and hepatocellular carcinoma.